EverSource Wealth Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

EverSource Wealth Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.91K	Sell	11 -16	-59%	-$8.2K	﹤0.01%	3208
2026 Q1	$14.1K	Buy	27 +22	+440%	+$10.5K	﹤0.01%	2729
2025 Q4	$2.91K	Buy	5 +1	+25%	+$511	﹤0.01%	3349
2025 Q3	$1.83K	Hold	4	–	–	﹤0.01%	3545
2025 Q2	$1.21K	Sell	4 -16	-80%	-$4.77K	﹤0.01%	3678
2025 Q1	$6.62K	Buy	20 +2	+11%	+$657	﹤0.01%	2353
2024 Q4	$5.55K	Sell	18 -1	-5%	-$281	﹤0.01%	2294
2024 Q3	$4.03K	Sell	19 -2	-10%	-$512	﹤0.01%	2310
2024 Q2	$5.98K	Buy	21 +4	+24%	+$952	﹤0.01%	2150
2024 Q1	$3.47K	Hold	17	–	–	﹤0.01%	2203
2023 Q4	$3.93K	Buy	17 +10	+143%	+$1.75K	﹤0.01%	1954
2023 Q3	$1.02K	Buy	7 +1	+17%	+$188	﹤0.01%	2207
2023 Q2	$1.39K	Buy	6 +2	+50%	+$542	﹤0.01%	2120
2023 Q1	$969	Buy	+4	New	+$1.09K	﹤0.01%	2124

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EverSource Wealth Advisors's MDGL Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Madrigal Pharmaceuticals (MDGL) stake by 59% in Q2 2026, selling an estimated $8.2K and leaving 11 shares worth $5.91K. The position accounts for ﹤0.01% of the portfolio, ranked #3208.

EverSource Wealth Advisors first reported a position in MDGL in Q1 2023 and has held it in 14 quarters since. The position peaked at $14.1K in Q1 2026. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

EverSource Wealth Advisors held 11 shares of Madrigal Pharmaceuticals worth $5.91K as of Q2 2026.
EverSource Wealth Advisors sold 16 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $8.2K.
Madrigal Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3208 holding.
EverSource Wealth Advisors first reported a position in Madrigal Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
EverSource Wealth Advisors's Madrigal Pharmaceuticals position peaked at $14.1K in Q1 2026.
414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.